1. Home
  2. AVO vs NRIX Comparison

AVO vs NRIX Comparison

Compare AVO & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVO
  • NRIX
  • Stock Information
  • Founded
  • AVO 1983
  • NRIX 2009
  • Country
  • AVO United States
  • NRIX United States
  • Employees
  • AVO N/A
  • NRIX N/A
  • Industry
  • AVO Farming/Seeds/Milling
  • NRIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AVO Consumer Staples
  • NRIX Health Care
  • Exchange
  • AVO Nasdaq
  • NRIX Nasdaq
  • Market Cap
  • AVO 870.7M
  • NRIX 908.0M
  • IPO Year
  • AVO 2020
  • NRIX 2020
  • Fundamental
  • Price
  • AVO $12.08
  • NRIX $12.73
  • Analyst Decision
  • AVO Strong Buy
  • NRIX Strong Buy
  • Analyst Count
  • AVO 2
  • NRIX 16
  • Target Price
  • AVO $15.50
  • NRIX $30.44
  • AVG Volume (30 Days)
  • AVO 519.8K
  • NRIX 747.9K
  • Earning Date
  • AVO 06-05-2025
  • NRIX 07-10-2025
  • Dividend Yield
  • AVO N/A
  • NRIX N/A
  • EPS Growth
  • AVO 108.17
  • NRIX N/A
  • EPS
  • AVO 0.52
  • NRIX N/A
  • Revenue
  • AVO $1,392,900,000.00
  • NRIX $56,417,000.00
  • Revenue This Year
  • AVO $8.85
  • NRIX $16.69
  • Revenue Next Year
  • AVO N/A
  • NRIX N/A
  • P/E Ratio
  • AVO $23.34
  • NRIX N/A
  • Revenue Growth
  • AVO 29.50
  • NRIX N/A
  • 52 Week Low
  • AVO $9.54
  • NRIX $8.18
  • 52 Week High
  • AVO $15.25
  • NRIX $29.56
  • Technical
  • Relative Strength Index (RSI)
  • AVO 58.90
  • NRIX 62.83
  • Support Level
  • AVO $11.53
  • NRIX $11.34
  • Resistance Level
  • AVO $12.10
  • NRIX $12.90
  • Average True Range (ATR)
  • AVO 0.34
  • NRIX 0.66
  • MACD
  • AVO -0.07
  • NRIX 0.02
  • Stochastic Oscillator
  • AVO 47.01
  • NRIX 90.17

About AVO Mission Produce Inc.

Mission Produce Inc is engaged in the business of producing and distributing avocados, serving retail, wholesale, and food service customers. Also, the company provides additional services like ripening, bagging, custom packing, and logistical management. The company's operating segments include Marketing and Distribution, International Farming and Blueberries. It generates maximum revenue from the Marketing and Distribution segment. The Marketing and Distribution segment sources fruit mainly from growers and then distributes fruit through a distribution network. Geographically distributed across North America, China, Europe, and the U.K.

About NRIX Nurix Therapeutics Inc. Common stock

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

Share on Social Networks: